The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Share News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Shaftesbury Down 13% Amid Fundraise Plans

Thu, 22nd Oct 2020 11:06

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.

----------

FTSE 250 - LOSERS

----------

Shaftesbury, down 13%, and Capital & Counties, down 11%. Shaftesbury said it intends to raise GBP307 million via the issue of new shares to ensure financial flexibility to navigate the "unprecedented" challenges created by the Covid-19 pandemic. Current market capitalisation is GBP1.33 billion. Capital & Counties Properties said it will participate in the Shaftesbury fundraise by providing GBP65 million.

----------

Moneysupermarket, down 5.7%, the price comparison website firm said revenue dropped across all of its businesses in the third quarter, with the company blaming the "disruption" caused by the pandemic. In the three months to September 30, Moneysupermarket's total revenue dropped 16% year on year to GBP85.1 million.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Premier African Minerals up 19%. The southern Africa-focused miner said it has settled all amounts it owes to directors, employees and other creditors, amounting to GBP600,057 of shares. Along with the GBP1.1 million placing, completed on Wednesday, the company is now debt free.

----------

OPG Power Ventures, up 16%. The Indian power plant operator said revenue in the year ended March 31 rose 9.5% to GBP154.0 million from GBP140.6 million. Pretax profit slipped 14% to GBP14.5 million from GBP16.9 million.

----------

4D Pharma up 16% after it proposed a merger with special-purpose acquisition company Longevity Acquisition Corp. Longevity shareholders will hold 13% of the enlarged firm. The deal values 4D Pharma shares at GBP1.10 each - an 18% premium to its GBP0.932 closing price on Wednesday - GBP144.5 million altogether. 4D's current market capitalisation is GBP141.1 million. The enlarged company will also launch an American depositary receipts programme, eyeing a Nasdaq listing.

----------

Pendragon up 12%, the motor retailer said it delivered a "very strong" third quarter, with total revenue down 14% annually, but up 1.2% like-for-like. Underlying pretax profit surged to GBP27.3 million from GBP3.0 million a year earlier. Opts not to reinstate annual guidance, however.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Kibo Energy, down 12% after the Africa-focused energy firm posted a narrowed loss in the six months to June 30. Its pretax loss slimmed to GBP1.3 million from GBP1.8 million, though like last year, it generated no revenue. Noted that Covid-19 has caused delays to its project development targets.

----------

Thalassa Holdings, dropped 12% after a regulatory filing showed investor Lombard Odier Asset Management Ltd trimmed its stake in the British Virgin Islands-based investment holding company to 1.4% from 14% during a transaction on Wednesday.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
16 Jun 2015 07:56

4D Pharma Says Has Identified Potential Multiple Sclerosis Candidate

Read more
5 Jun 2015 11:04

4d Pharma posts losses of £2.38m in maiden results

Pharmaceutical company 4d Pharma has reported losses of £2.38m in its maiden set of full-year results. Basic losses per share totalled 4.81p. 4d, which uses selected bacteria to develop treatments, said that during the period its cash, cash equivalents, deposits and short-term investments increased

Read more
5 Jun 2015 09:13

4D Pharma Says "Excited" By Prospects In Maiden Full Year Results

Read more
20 May 2015 09:56

4d Pharma Submits Plans For Blautix Trial, Progressing With Thetanix

Read more
30 Mar 2015 14:53

4D Pharma Acquires Remaining Share In GT Biologics

Read more
9 Feb 2015 08:27

UK MORNING BRIEFING: Chinese And German Trade Figures Hit Shares

Read more
9 Feb 2015 06:15

UK AGM, EGM Calendar - Week Ahead

Read more
6 Feb 2015 16:01

UK AGM, EGM Calendar - Week Ahead

Read more
6 Feb 2015 06:17

UK AGM, EGM Calendar - Week Ahead

Read more
5 Feb 2015 16:00

UK AGM, EGM Calendar - Week Ahead

Read more
5 Feb 2015 06:24

UK AGM, EGM Calendar - Week Ahead

Read more
4 Feb 2015 15:58

UK AGM, EGM Calendar - Week Ahead

Read more
4 Feb 2015 06:15

UK AGM, EGM Calendar - Week Ahead

Read more
3 Feb 2015 16:00

UK AGM, EGM Calendar - Week Ahead

Read more
3 Feb 2015 06:15

UK AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.